Pharmacy Reaches 503B Milestone With Long-Term Sustainability Plan

Compounding Pharmacy Secures FDA Registration

Share this case study!
Life SciencesLife Sciences

Industry

Pharmaceutical Manufacturing

Location

United States

The project’s key achievement was helping the client meet complex FDA and USP standards, positioning their pharmacy to safely expand services and reduce outsourcing costs.

Vision

This client is a large not-for-profit health system operating its own central compounding pharmacy to serve patients across multiple hospitals and clinics. Facing heightened regulatory scrutiny, they needed to secure FDA 503B outsourcing facility registration and align operations with strict USP 797 and USP 800 standards for sterile and hazardous drug compounding. Without expert guidance, they risked compliance gaps, operational delays, and higher third-party outsourcing costs. Trinity’s regulatory and technical specialists were brought in to navigate the complex registration process and create a clear, achievable action plan.

Partnership

Trinity’s team worked closely with the client to develop a comprehensive strategy for FDA registration and compliance readiness. We assessed existing operations, identified gaps, and guided facility upgrades and process improvements to meet federal requirements. By coordinating directly with regulators and the client’s internal teams, we ensured a smooth path to registration and long-term operational sustainability.

Services Performed

The team developed a regulatory strategy and provided FDA 503B registration support to ensure the client’s outsourcing facility met stringent compliance requirements. They conducted gap assessments for USP 797 and USP 800, identifying areas for improvement and guiding corrective actions. Facility design and operational processes were optimized to align with best practices, while staff training and quality system enhancements strengthened overall compliance and operational efficiency.

Value-Add

Trinity’s targeted approach enabled the health system’s pharmacy to achieve FDA outsourcing facility registration on schedule, maintain full compliance with USP standards, and significantly reduce reliance on external compounding vendors. This expanded safe prescription access for patients, lowered overall costs, and strengthened the client’s commitment to high-quality in-house care.

80+

SOPs Developed

12+

Hospitals Supported

Related Resources

EPA Proposal Could Ease Permitting for Portable Turbines Used in Temporary Power
EPA Proposal Could Ease Permitting for Portable Turbines Used in Temporary Power
Read More
Food Safety Implications of SJVAPCD Amendments to Rule 4663
Food Safety Implications of SJVAPCD Amendments to Rule 4663
Read More
Quality Assurance Services Service Sheet
Quality Assurance Services Service Sheet
Read More
EPA Proposes Broad Changes to NSPS OOOOb and EG OOOOc
EPA Proposes Broad Changes to NSPS OOOOb and EG OOOOc
Read More
Relief Design Basis Matters: Protecting People, Plants, and Compliance
Relief Design Basis Matters: Protecting People, Plants, and Compliance
Read More

Related Upcoming Events

NCASI
Dec 9-10, 2026
PCWP MACT Compliance Workshop
Read More
Indiana Winter Technical Conference
Dec 3, 2026
2026 Winter Technical Meeting/Environmental Conference
Read More
NEBC Business & the Environment
Dec 8-9, 2026
NEBC Business & the Environment
Read More
SafeBridge® Global Potent Compound Congress & Expo
May 5-6, 2027
2027 SafeBridge® Global Potent Compound Congress & Expo
Read More